Literature DB >> 24506652

Mammographic compression after breast conserving therapy: controlling pressure instead of force.

J E de Groot1, M J M Broeders2, W Branderhorst1, G J den Heeten3, C A Grimbergen1.   

Abstract

PURPOSE: X-ray mammography is the primary tool for early detection of breast cancer and for follow-up after breast conserving therapy (BCT). BCT-treated breasts are smaller, less elastic, and more sensitive to pain. Instead of the current force-controlled approach of applying the same force to each breast, pressure-controlled protocols aim to improve standardization in terms of physiology by taking breast contact area and inelasticity into account. The purpose of this study is to estimate the potential for pressure protocols to reduce discomfort and pain, particularly the number of severe pain complaints for BCT-treated breasts.
METHODS: A prospective observational study including 58 women having one BCT-treated breast and one untreated nonsymptomatic breast, following our hospital's 18 decanewton (daN) compression protocol was performed. Breast thickness, applied force, contact area, mean pressure, breast volume, and inelasticity (mean E-modulus) were statistically compared between the within-women breast pairs, and data were used as predictors for severe pain, i.e., scores 7 and higher on an 11-point Numerical Rating Scale. Curve-fitting models were used to estimate how pressure-controlled protocols affect breast thickness, compression force, and pain experience.
RESULTS: BCT-treated breasts had on average 27% smaller contact areas, 30% lower elasticity, and 30% higher pain scores than untreated breasts (all p < 0.001). Contact area was the strongest predictor for severe pain (p < 0.01). Since BCT-treatment is associated with an average 0.36 dm(2) decrease in contact area, as well as increased pain sensitivity, BCT-breasts had on average 5.3 times higher odds for severe pain than untreated breasts. Model estimations for a pressure-controlled protocol with a 10 kPa target pressure, which is below normal arterial pressure, suggest an average 26% (range 10%-36%) reduction in pain score, and an average 77% (range 46%-95%) reduction of the odds for severe pain. The estimated increase in thickness is +6.4% for BCT breasts.
CONCLUSIONS: After BCT, women have hardly any choice in avoiding an annual follow-up mammogram. Model estimations show that a 10 kPa pressure-controlled protocol has the potential to reduce pain and severe pain particularly for these women. The results highly motivate conducting further research in larger subject groups.

Entities:  

Mesh:

Year:  2014        PMID: 24506652     DOI: 10.1118/1.4862512

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Finite element model of mechanical imaging of the breast.

Authors:  Rebecca Axelsson; Hanna Tomic; Sophia Zackrisson; Anders Tingberg; Hanna Isaksson; Predrag R Bakic; Magnus Dustler
Journal:  J Med Imaging (Bellingham)       Date:  2022-05-23

2.  Pain-preventing strategies in mammography: an observational study of simultaneously recorded pain and breast mechanics throughout the entire breast compression cycle.

Authors:  Jerry E de Groot; Mireille J M Broeders; Cornelis A Grimbergen; Gerard J den Heeten
Journal:  BMC Womens Health       Date:  2015-03-15       Impact factor: 2.809

3.  Mammographic compression in Asian women.

Authors:  Susie Lau; Yang Faridah Abdul Aziz; Kwan Hoong Ng
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

4.  Evaluation of pressure-controlled mammography compression paddles with respect to force-controlled compression paddles in clinical practice.

Authors:  C R L P N Jeukens; T van Dijk; C Berben; J E Wildberger; M B I Lobbes
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

Review 5.  Mammographic compression practices of force- and pressure-standardisation protocol: A scoping review.

Authors:  Elizabeth Serwan; Donna Matthews; Josephine Davies; Minh Chau
Journal:  J Med Radiat Sci       Date:  2020-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.